Our CJC-1295 (no DAC) 10mg is synthesized with precision to ensure maximum purity and consistency for your experimental protocols
As the clinical landscape for GLP-1s continues to evolve, were committed to supporting plan sponsors with evidence-based, clinically appropriate coverage, cost, and care solutions that can help control spend without compromising health outcomes.
Discussing Your Treatment Plan with Your Healthcare Provider The decision of how long to stay on compounded GLP-1 medications is a collaborative one between you and your healthcare provider
The Importance of the Titration Schedule The journey with semaglutide is a marathon, not a sprint
The results were striking: participants on oral semaglutide achieved a mean weight loss of 13.6%, compared to just 2.2% on placebo
Your provider submits the request The prescriber attests that you meet the criteria and submits a prior authorization through the central processor CMS set up for the Bridge